 Investigators will conduct the trial to determine whether paclitaxel and cisplatin PT has the same curative effects and less adverse effects than bleomycin, etoposide and cisplatinBEP among newly diagnosed ovarian malignant sex cord-stromal tumor patients after surgery. 